Contributing Member of the Healthcare Councils

GLG News by this Author

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Ketamine to treat severe depression

February 2, 2012

Ketamine got its start as a veterinarian tranquilizer and  later it appeared as a club drug called “Special K”.  About 10 years ago a group of physicians in Connecticut noticed that Ketamine helped to improve depressive symptoms when it was given to children as a general anesthetic.

U.S. lags in wind and solar power use

November 30, 2011

Currently wind and solar power make up only 1 % of the energy generated in the U.S.

Levomilnacipram from Forest Pharmaceuticals looks very promising for major depressive disorder

November 30, 2011

Levomilnacipram SR  (F2695)  is a  new  SNRI  antidepressant currently under study by Forest Pharmaceuticals and Pierre Fabre Medicament.

Cariprazine shows promise in late stage Bipolar trial

November 1, 2011

In trials the once a day experimental drug caused few side effects.

Bapineuzumab for the Treatment of Alzheimer's Dementia

September 12, 2011

Bapineuzumab is an experimental vaccine treatment for Alzheimer’s dementia , which consists of a human monoclonal antibody, which selectively binds to and dissolves beta amyloid plaques in the brain. 

FazaClo for the treatment of Schizophrenia

July 23, 2011

This article will explore FazoClo for the treatment of Schizophrenia.

Chymotrypsin for Autism Spectrum Disorders

July 17, 2011

This article will explore a new type of treatment for Autism Spectrum Disorders.

Sativex for MS spasticity

June 26, 2011

This article will explore Sativex for MS spasticity.

Viibryd from Forest Pharmaceutical

June 11, 2011

This article will explore Viibryd, the unique new antidepressant from Forest Pharmaceutical.

New Hearing Aid Technology

April 2, 2011

This Article explores the cost issue of hearing aids

Intranasal Oxytocin for the treatment of Autism Spectrum Disorders.

March 10, 2011

This article will explore Intranasal Oxytocin for the treatment of Autism Spectrum Disorders.

Viibryd approved by the FDA

February 9, 2011

This article will explore the new antidepressant, Viibryd from Clinical Data, which the FDA recently approved.

RG 1678 looks promising for the treatment of Schizophrenia

January 28, 2011

This article will explore RG 1678, a new schizophrenia drug, form Roche.

VNS Therapy for the treatment of Major Depression

January 6, 2011

This article will explore the use of VNS therapy for Major Depression.

Vilazodone looks very promising

December 21, 2010

This article will explore the new antidepressant  from Clinical Data called Vilazodone.

TC-5214 The next generation of anti-depressant therapy

December 13, 2010

This article explores TC-5214, a unique drug being developed for the treatment of Major Depression by Targacept and Astra Zenica.

Vivitrol gets a new indication

December 12, 2010

This article will explore the Alkermes drug Vivitrol.

Nuedexta the first approved treatment for Pseudobulbar Affect

December 4, 2010

This article will explore the new drug from Avanir Pharmaceutical called Nuedextra.

Silenor a unique option for insomnia

November 20, 2010

This article will explore Silenor for the treatment of insomnia.

Latuda approved by FDA

November 19, 2010

This article will discuss the recent FDA approval of Latuda.

Page : 1234Next1 to 20 of 75